Aeterna Zentaris
AEZS
#10806
Rank
C$24.95 M
Marketcap
C$8.15
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): C-$2.77

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is C-$2.92. In 2022 the company made an earnings per share (EPS) of C-$6.67 a decrease over its 2021 EPS that were of C-$2.59.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C-$2.77
2022C-$6.67157.14%
2021C-$2.59-41.48%
2020C-$4.43-64.46%
2019C-$12.47-240%
2018C$8.90-122.32%
2017C-$39.89-53.53%
2016C-$85.84-86.71%
2015C-$646.10-35.21%
2014C-$997.29-216.67%
2013C$854.82-123.3%
2012C-$3,669-40.8%
2011C-$6,197-6.45%
2010C-$6,625-27.91%
2009C-$9,189-61.61%
2008C-$23,93583.61%
2007C-$13,036-195.31%
2006C$13,677178.26%
2005C$4,915-330%
2004C-$2,137-80.05%
2003C-$10,71217.78%
2002C-$9,095515.93%
2001C-$1,477-68.6%
2000C-$4,703119.62%
1999C-$2,141-3.63%
1998C-$2,222

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$9.49-425.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$2.71-192.88%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$6.47-321.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.51-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
C$5.01-271.80%๐Ÿ‡บ๐Ÿ‡ธ USA